美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Everolimus	Tablet			Develop a dissolution method			2023/09/15
Exemestane	Tablet			Develop a dissolution method			2023/09/15
Exenatide Synthetic (2 mg)	For Suspension, Extended Release			Develop a method to characterize in vitro release			2022/07/07
Exenatide Synthetic (2 mg/0.85 mL)	Suspension, Extended Release			Develop a method to characterize in vitro release			2022/07/07
Ezetimibe	Tablet	II (Paddle)	50	0.45% SLS in 0.05 M Acetate Buffer, pH 4.5	500	10, 20, 30 and 45	2008/01/14
Ezetimibe/Simvastatin	Tablet	II (Paddle)	50	0.01 M Sodium Phosphate, pH 7.0/0.5% SDS	900	5, 10, 20 and 30	2007/01/03
Ezogabine	Tablet	II (Paddle)	75	0.01 N HCl	1000	5, 10, 15, 20 and 30	2013/08/15
Famciclovir	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Famotidine	Tablet (Orally Disintegrating)	II (Paddle)	50	0.1 M Phosphate Buffer, pH 4.5	900	2, 5, 10, 15 and 20	2008/10/06
Famotidine	Tablet (Chewable)	II (Paddle)	50	0.1 M Phosphate Buffer, pH 4.5	900	10, 20, 30, 45 and 60	2004/01/29
Famotidine	Tablet			Refer to USP			2023/02/09
Famotidine	Suspension	II (Paddle)	25 and 50	0.1 M Phosphate buffer, pH 4.5	900	10, 15, 30 and 45	2008/11/25
Famotidine/Calcium Carbonate/Magnesium Hydroxide	Tablet (Chewable)			Develop a dissolution method			2009/12/15
Famotidine/Ibuprofen	Tablet	II (Paddle)	50	0.05 M Phosphate Buffer, pH 7.2	900	5, 10, 15, 20, 30 and 45	2013/08/15
Febuxostat	Tablet	II (Paddle)	75	0.05 M Phosphate Buffer, pH 6.0	900	5, 10, 15, 20 and 30	2013/08/15
Fedratinib HCl	Capsule	I (Basket)	50	0.1 N HCl	900	5, 10, 15, 20 and 30	2021/08/19
Felbamate	Suspension			Develop a dissolution method			2023/09/15
Felbamate	Tablet			Develop a dissolution method			2024/01/03
Felodipine	Tablet (Extended Release)			Develop a dissolution method			2024/01/03
Fenofibrate	Capsule	II (Paddle)	75	Phosphate Buffer w/ 2% Tween 80 and 0.1% pancreatin, pH 6.8	900	15, 30, 45, 60, 90 and 120	2008/02/19